Joincare Pharmaceutical Group IndustryLtd Balance Sheet Health
Financial Health criteria checks 5/6
Joincare Pharmaceutical Group IndustryLtd has a total shareholder equity of CN¥23.1B and total debt of CN¥5.0B, which brings its debt-to-equity ratio to 21.5%. Its total assets and total liabilities are CN¥36.5B and CN¥13.4B respectively. Joincare Pharmaceutical Group IndustryLtd's EBIT is CN¥2.8B making its interest coverage ratio -5.8. It has cash and short-term investments of CN¥15.7B.
Key information
21.5%
Debt to equity ratio
CN¥4.98b
Debt
Interest coverage ratio | -5.8x |
Cash | CN¥15.73b |
Equity | CN¥23.11b |
Total liabilities | CN¥13.38b |
Total assets | CN¥36.50b |
Recent financial health updates
We Think Joincare Pharmaceutical Group IndustryLtd (SHSE:600380) Can Manage Its Debt With Ease
Jun 23Recent updates
Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) Business And Shares Still Trailing The Market
Aug 13We Think Joincare Pharmaceutical Group IndustryLtd (SHSE:600380) Can Manage Its Debt With Ease
Jun 23Shareholders Will Probably Hold Off On Increasing Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) CEO Compensation For The Time Being
May 31Joincare Pharmaceutical Group IndustryLtd's (SHSE:600380) Conservative Accounting Might Explain Soft Earnings
Apr 09Investors Don't See Light At End Of Joincare Pharmaceutical Group Industry Co.,Ltd.'s (SHSE:600380) Tunnel
Mar 04Financial Position Analysis
Short Term Liabilities: 600380's short term assets (CN¥23.6B) exceed its short term liabilities (CN¥11.1B).
Long Term Liabilities: 600380's short term assets (CN¥23.6B) exceed its long term liabilities (CN¥2.3B).
Debt to Equity History and Analysis
Debt Level: 600380 has more cash than its total debt.
Reducing Debt: 600380's debt to equity ratio has increased from 8.7% to 21.5% over the past 5 years.
Debt Coverage: 600380's debt is well covered by operating cash flow (88.6%).
Interest Coverage: 600380 earns more interest than it pays, so coverage of interest payments is not a concern.